Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology iHuPDX Platform

Author:

InnoModels

Release time:

2024-09-03

In the biomedical field, innovation is a key driver for technological advancement and clinical application. With its iHuPDX (Individualized Human Patient-Derived Xenograft) platform, InnoModels Biotechnology (Beijing) Co., Ltd. is bringing unprecedented changes to cancer research and treatment. iHuPDX platform not only demonstrates InnoModels BioTech's profound strength in the field of personalized medicine, but also provides new hopes and possibilities for tumor treatment. The iHuPDX platform not only demonstrates the profound strength of Thermo Scientific in the field of personalized medicine, but also provides new hope and possibilities for tumor treatment.
Background and Technical Principle of iHuPDX Platform
The iHuPDX platform is a xenotransplantation technology based on patients' individual tumor cells, aiming to establish a more realistic and individualized cancer model. The technology collects cancer tissue samples from patients and transplants them into animals such as mice to form individualized transplanted tumors. This highly individualized disease model can more accurately simulate the biological characteristics of a patient's tumor, such as growth, metastasis and drug response, providing strong support for precision medicine.
Advantages and applications of iHuPDX platform
1. Accurately simulate patients' tumor characteristics
Traditional tumor models are often based on standardized cell lines or tissue samples, which cannot fully reflect the uniqueness of patient tumors. The iHuPDX platform, on the other hand, is derived directly from the patient's tumor cells, and is therefore able to more accurately simulate the growth and metastasis of the patient's tumor. This individualized disease model not only helps doctors to understand the patient's tumor characteristics more comprehensively, but also provides an important basis for the development of personalized treatment plans.
2. Drug response prediction
Due to the high degree of similarity between the iHuPDX platform and the patient's tumor, researchers can test the response of different drugs to a specific patient's tumor on the model, thus predicting the drug's efficacy and possible side effects in the patient. This predictive capability enables physicians to select the most appropriate drug combination and dosage for a patient before treatment, increasing the success rate of treatment and reducing unnecessary risks.
3. Broad Application Areas
The iHuPDX platform has a wide range of applications in the fields of cancer research, drug development, tumor biology research, and tumor immunity-related research. It not only provides researchers with experimental animal models that are closer to the clinic, but also promotes the development of new drug development and translational medicine. Through this platform, researchers are able to explore more deeply the differences in tumor heterogeneity among different patients, reveal the diversity of cancers, and provide important information for the development of individualized treatment strategies.

Strength and Future Prospects of InnoModels Biotechnology
Founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion, and the Institute of Immunology of Shanghai Jiaotong University, InnoModels Biotechnology (Beijing) Ltd. is endowed with rich scientific research resources and strong technical support. With a stable domestic platform of humanized mouse model of immune system (HIS) and human tumor xenograft platform (PDX), the company is committed to providing the most clinically referenced preclinical research support for oncology and tumor immunotherapy innovators.
InnoModels Biotechnology is confident in the future of the iHuPDX platform. With the deepening of biomedical research and continuous technological innovation, the iHuPDX platform is expected to play a more important role in the field of personalized medicine. In the future, we can expect to see more research results and application scenarios related to the iHuPDX platform, which will bring hope and gospel to more patients.
Conclusion
With its unique advantages and wide range of application areas, iHuPDX platform of InnoModels Biotechnology is leading the new trend of personalized medicine. By providing highly individualized tumor models for medical research and drug development, the iHuPDX platform brings new possibilities for precision cancer treatment. InnoModels Biotechnology will continue to devote itself to promoting the development of this technology, providing patients with more effective treatment options, and contributing to the continuous progress of the biomedical field.

InnoModels Biotechnology PDC In Vitro High-Throughput Pharmacodynamic Evaluation Platform

InnoModels Biotechnology Brain In Situ Model

InnoModels Biotechnology PDC In Vitro High-Throughput Pharmacodynamic Evaluation Platform

InnoModels Biotechnology Brain In Situ Model

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License